A Randomized, Open-label, Two-arm, Two-period, Multiple-dose, Study to Evaluate Pharmacokinetic Drug-drug Interaction, Safety and Tolerability of UIC202601 and UIC202602 in Healthy Volunteers

NCT07682948 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension
Dyslipidemia

Interventions

DRUG: Investigational Product 1
DRUG: Investigational Product 2
DRUG: Investigational Product 1 + Investigational Product 2

Sponsor

Korea United Pharm. Inc.